4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-23-004761
CVP, EMEACLA and JAPAC sold 6,640 shares at $83.10 ($551,766)
- CVP, EMEACLA and JAPAC acquired 6,640 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lemercier Jean-Luc M · CVP, EMEACLA and JAPAC
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,640 | $35.20 | $233,706 | 175,777.78 | D |
| 2023-04-06 | Sale : show line 2 in the form 10b5-1 | −6,640 | $83.10 | $551,766 | 169,137.78 | D |
| Open-market sales · 6,640 sh · avg $83.10 · $551,766 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-04-06 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −6,640 | $35.20 | 2023-05-11 | 6,640 | 6,640 | D |
Loading xslF345X04/doc4.xml…